Immunome (IMNM) Amortizatization of Intangibles (2022 - 2025)
Immunome (IMNM) reported Amortizatization of Intangibles of $2.5 million for Q4 2025, little changed on a YoY basis from $2.5 million in Q4 2024, and up 1634.03% quarter-over-quarter from $144000.0 in Q3 2025.
Immunome (IMNM) Amortizatization of Intangibles (2022 - 2025) Analysis & Trends
Immunome has reported Amortizatization of Intangibles for 4 years, with the latest figure at $2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles changed 0.48% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 44.03% YoY), and the FY2025 full-year result was $2.8 million, down 2.07% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $2.5 million, up from $144000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.5 million in Q4 2024, with the low at -$620000.0 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $403687.5 across 4 years, with a median of $81000.0 in 2023.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles sank 4118.18% — and 2024, when it surged 1300.0%.
- Immunome's Amortizatization of Intangibles stood at $165000.0 in 2022, then jumped by 411.52% to $844000.0 in 2023, then jumped by 197.27% to $2.5 million in 2024, then dropped by 0.48% to $2.5 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $2.5 million (Q4 2025), $144000.0 (Q3 2025), and -$620000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 144,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Jun 30, 2025 | -620,000.00 |
| Jun 30, 2025 | -620,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Dec 31, 2024 | 2.51 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | -500,000.00 |
| Sep 30, 2024 | -500,000.00 |
| Jun 30, 2024 | 784,000.00 |
| Jun 30, 2024 | 784,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 844,000.00 |
| Dec 31, 2023 | 844,000.00 |
| Sep 30, 2023 | -442,000.00 |
| Sep 30, 2023 | -442,000.00 |